The role of erythropoietin (Ep) in the regulation of erythroid committed precursor (ECP) population size was studied. Experiments were performed on polycythemic CBA mice treated with cyclophosphamide (Cy) on the 5th day after hypertransfusion. In these animals no erythropoietin-responsive cell (ERC) regeneration could be detected up to day 10 after Cy. The results obtained demonstrate that regeneration of ERC could be prompted if the test dose of Ep(2 U) was preceded by daily injections of 1 U Ep. Furthermore, one injection of 5 U Ep given 72 h before Ep test dose, at the time when pre-ERC were nearly completely recovered, was sufficient to stimulate ERC regeneration. At the same time hydroxyurea suicide was not changed in polycythemic mice treated with Cy and daily Ep injections as compared to control animals. The results indicate that Ep does not stimulate only the multiplication of ERC bu also progression of pre-ERC to ERC. In this way the population size of regenerating ECP is Ep dependent.

Keywords:
ECP population size, Erythropoietin, Erythropoietin-responsive cell, Regeneration
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.